These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 7784092
1. RET mutations in exons 13 and 14 of FMTC patients. Bolino A, Schuffenecker I, Luo Y, Seri M, Silengo M, Tocco T, Chabrier G, Houdent C, Murat A, Schlumberger M. Oncogene; 1995 Jun 15; 10(12):2415-9. PubMed ID: 7784092 [Abstract] [Full Text] [Related]
2. A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families. Marsh DJ, Robinson BG, Andrew S, Richardson AL, Pojer R, Schnitzler M, Mulligan LM, Hyland VJ. Genomics; 1994 Sep 15; 23(2):477-9. PubMed ID: 7835899 [Abstract] [Full Text] [Related]
3. A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC. Chiefari E, Chiarella R, Crocetti U, Tardio B, Arturi F, Russo D, Trischitta V, Filetti S, Zingrillo M. Horm Metab Res; 2001 Jan 15; 33(1):52-6. PubMed ID: 11280716 [Abstract] [Full Text] [Related]
4. A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening. Kaldrymides P, Mytakidis N, Anagnostopoulos T, Vassiliou M, Tertipi A, Zahariou M, Rampias T, Koutsodontis G, Konstantopoulou I, Ladopoulou A, Bei T, Yannoukakos D. Clin Endocrinol (Oxf); 2006 May 15; 64(5):561-6. PubMed ID: 16649977 [Abstract] [Full Text] [Related]
5. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal. Prazeres HJ, Rodrigues F, Figueiredo P, Naidenov P, Soares P, Bugalho MJ, Lacerda M, Campos B, Martins TC. Clin Endocrinol (Oxf); 2006 Jun 15; 64(6):659-66. PubMed ID: 16712668 [Abstract] [Full Text] [Related]
6. Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma. Marsh DJ, Andrew SD, Eng C, Learoyd DL, Capes AG, Pojer R, Richardson AL, Houghton C, Mulligan LM, Ponder BA, Robinson BG. Cancer Res; 1996 Mar 15; 56(6):1241-3. PubMed ID: 8640806 [Abstract] [Full Text] [Related]
7. [Neural crest and multiple endocrinopathies]. Pasini A, Michiels FM, Chappuis-Flament S, Geneste O, Rossel M, Fournier L, Feunteun J, Lenoir G, Schuffenecker I, Billaud M. C R Seances Soc Biol Fil; 1996 Mar 15; 190(5-6):557-67. PubMed ID: 9074721 [Abstract] [Full Text] [Related]
8. Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Mulligan LM, Eng C, Attié T, Lyonnet S, Marsh DJ, Hyland VJ, Robinson BG, Frilling A, Verellen-Dumoulin C, Safar A. Hum Mol Genet; 1994 Dec 15; 3(12):2163-7. PubMed ID: 7881414 [Abstract] [Full Text] [Related]
9. [Multiple endocrine neoplasia type 2A, type 2B and familial medullary thyroid carcinoma syndrome]. Obara T, Yamashita T, Kanbe M, Ito Y, Egawa S, Yamaguchi K. Nihon Rinsho; 1995 Nov 15; 53(11):2708-15. PubMed ID: 8538031 [Abstract] [Full Text] [Related]
10. [Genetic analysis of RET mutations in families with multiple endocrine neoplasia type II in the community of Murcia]. Pomares Gómez FJ, Bernabé Espinosa MJ, Matías-Guiu Guía X, Rodríguez González JM, Soriano Palao J, Sola Pérez J, Carbonell Meseguer P, Parrilla Paricio P, Tébar Massó FJ. Med Clin (Barc); 1999 May 15; 112(17):646-50. PubMed ID: 10374185 [Abstract] [Full Text] [Related]
11. Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds. Dvorakova S, Vaclavikova E, Ryska A, Cap J, Vlcek P, Duskova J, Kodetova D, Holub V, Novak Z, Bendlova B. Exp Clin Endocrinol Diabetes; 2006 Apr 15; 114(4):192-6. PubMed ID: 16705552 [Abstract] [Full Text] [Related]
13. Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients. Fernández RM, Navarro E, Antiñolo G, Ruiz-Ferrer M, Borrego S. Int J Mol Med; 2006 Apr 15; 17(4):575-81. PubMed ID: 16525712 [Abstract] [Full Text] [Related]
16. Cys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung's disease. Nishikawa M, Murakumo Y, Imai T, Kawai K, Nagaya M, Funahashi H, Nakao A, Takahashi M. Eur J Hum Genet; 2003 May 15; 11(5):364-8. PubMed ID: 12734540 [Abstract] [Full Text] [Related]
17. Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas. Komminoth P, Kunz EK, Matias-Guiu X, Hiort O, Christiansen G, Colomer A, Roth J, Heitz PU. Cancer; 1995 Aug 01; 76(3):479-89. PubMed ID: 8625130 [Abstract] [Full Text] [Related]
18. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B. Zhou Y, Zhao Y, Cui B, Gu L, Zhu S, Li J, Liu J, Yin M, Zhao T, Yin Z, Yu C, Chen C, Wang L, Xiao B, Hong J, Zhang Y, Tang Z, Wang S, Li X, Ning G. Clin Endocrinol (Oxf); 2007 Oct 01; 67(4):570-6. PubMed ID: 17573899 [Abstract] [Full Text] [Related]
19. Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma. Shirahama S, Ogura K, Takami H, Ito K, Tohsen T, Miyauchi A, Nakamura Y. J Hum Genet; 1998 Oct 01; 43(2):101-6. PubMed ID: 9621513 [Abstract] [Full Text] [Related]
20. Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A. Landsvater RM, Jansen RP, Hofstra RM, Buys CH, Lips CJ, Ploos van Amstel HK. Hum Genet; 1996 Jan 01; 97(1):11-4. PubMed ID: 8557249 [Abstract] [Full Text] [Related] Page: [Next] [New Search]